2 March 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq:UTHR) announced on Monday that its long-term pivotal phase 3 ADVANCE OUTCOMES study of ralinepag met the primary endpoint, showing a 55% reduction in the risk of clinical wo...
2 March 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Monday that its Phase III FENhance 1 study in relapsing multiple sclerosis (RMS) met the primary endpoint, showing that fenebrutin...
2 March 2026 - Life science company ValiRx PLC (AIM: VAL) revealed on Monday that it has established a wholly owned subsidiary, ValiRx Animal Health Limited, to develop and commercialise its oncology assets within the veterinary market.The new entity...
2 March 2026 - Japanese pharmaceutical company Takeda (TSE:4502) (NYSE:TAK) and US biopharmaceutical company Protagonist Therapeutics Inc (NASDAQ:PTGX) announced on Monday that the US Food and Drug Administration (FDA) has accepted the New Drug Appli...